Shao; Yuefei

Patent Applications and Registrations

Patent applications and USPTO patent grants for Shao; Yuefei.The latest application filed is for "preparation and use of compounds as protease inhibitors".

Company Profile

0.16.16

Shao; Yuefei - Princeton NJ US
Shao; Yuefei - US
Shao; Yuefei - Dayton NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Heterocyclic aspartyl protease inhibitors Grant 8,829,036 - Zhu , et al. September 9, 2	2014-09-09
Preparation And Use Of Compounds As Protease Inhibitors App 20140206715 - Stamford; Andrew W. ; et al.	2014-07-24
Substituted isoindolines as aspartyl protease inhibitors Grant 8,722,708 - Stamford , et al. May 13, 2	2014-05-13
Heterocyclic aspartyl protease inhibitors Grant 8,691,833 - Zhu , et al. April 8, 2	2014-04-08
Heterocyclic aspartyl protease inhibitors Grant 8,691,831 - Zhu , et al. April 8, 2	2014-04-08
Heterocyclic Aspartyl Protease Inhibitors App 20120276118 - Zhu; Zhaoning ; et al.	2012-11-01
Heterocyclic Aspartyl Protease Inhibitors App 20120231018 - Zhu; Zhaoning ; et al.	2012-09-13
Heterocyclic Aspartyl Protease Inhibitors App 20120231017 - ZHU; ZHAONING ; et al.	2012-09-13
Heterocyclic substituted piperazines with CXCR3 antagonist activity Grant 8,207,170 - Kim , et al. June 26, 2	2012-06-26
Heterocyclic Substituted Piperazines With Cxcr3 Antagonist Activity App 20110065651 - Kim; Seong Heon ; et al.	2011-03-17
Heterocyclic substituted piperazines with CXCR3 antagonist activity Grant 7,868,006 - Kim , et al. January 11, 2	2011-01-11
Pyrazinyl substituted piperazine-piperidines with CXCR3 antagonist activity Grant 7,868,005 - Rosenblum , et al. January 11, 2	2011-01-11
Pyridyl and phenyl substituted piperazine-piperidines with CXCR3 antagonist activity Grant 7,776,862 - McGuinness , et al. August 17, 2	2010-08-17
Piperazine-piperidines with CXCR3 antagonist activity Grant 7,763,616 - Yu , et al. July 27, 2	2010-07-27
Heterocyclic aspartyl protease inhibitors Grant 7,763,609 - Zhu , et al. July 27, 2	2010-07-27
Amine-linked pyridyl and phenyl substituted piperazine-piperidines with CXCR3 antagonist activity Grant 7,566,718 - Wong , et al. July 28, 2	2009-07-28
Purinone derivatives for treating neurodegenerative diseases App 20090023723 - Cole; Andrew G. ; et al.	2009-01-22
Heterocyclic aspartyl protease inhibitors App 20080200445 - Zhu; Zhaoning ; et al.	2008-08-21
Preparation and use of compounds as protease inhibitors App 20080176868 - Stamford; Andrew ; et al.	2008-07-24
2-Aminoimidazopyridines for treating neurodegenerative diseases App 20080146536 - Cole; Andrew G. ; et al.	2008-06-19
Pyrazinyl substituted piperazine-piperidines with CXCR3 antagonist activity App 20070054919 - Rosenblum; Stuart B. ; et al.	2007-03-08
Pyridyl and phenyl substituted piperazine-piperidines with CXCR3 antagonist activity App 20070021611 - McGuinness; Brian F. ; et al.	2007-01-25
Heterocyclic substituted piperazines with CXCR3 antagonist activity App 20060276479 - Kim; Seong Heon ; et al.	2006-12-07
Amine-linked pyridyl and phenyl substituted piperazine-piperidines with CXCR3 antagonist activity App 20060276480 - Wong; Michael K. C. ; et al.	2006-12-07
Piperazine-piperidines with CXCR3 antagonist activity App 20060276457 - Yu; Wensheng ; et al.	2006-12-07
Aryl and biaryl piperdines with MCH modulatory activity Grant 6,887,889 - Hobbs , et al. May 3, 2	2005-05-03
Aryl and biaryl piperidines with MCH modulatory activity App 20030013720 - Hobbs, Douglas W. ; et al.	2003-01-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.